Table 2 Study endpoints
Characteristic | Remifentanil (n = 57) | Comparator (n = 48) | P |
|---|---|---|---|
Number (%) of patients extubated | 29 (51%) | 16 (33%) | |
Time from start of study drugs to weaning (h) | 83.0 | 98.0 | 0.523 |
Difference (95% CI) | -15.0 (-61.8 to 31.8) | ||
Time from start of study drugs to extubation(h) | 94.0 | 147.5 | 0.033 |
Difference (95% CI) | -53.5 (-111.4 to 4.4) | ||
Time from weaning time until extubation (h) | 0.9 | 27.5 | <0.001 |
Difference (95% CI) | -26.6 (-40.8 to -12.4) | ||
Time from start of study drugs until ICU discharge (h) | 187.3 | 209.8 | 0.326 |
Difference (95% CI) | -22.5 (-201.5 to 156.5) |